• S-Network Global Indexes
  • Posted November 1, 2018

Rule Change for Poliwogg Medical Breakthroughs Index

New York, NY, November 1, 2018 — The Poliwogg Medical Breakthroughs Index Committee today announced the following rule change to be effective for the Q4 2018 reconstitution and going forward, reflected in Sections I (General Description) and IV (Eligibility Criteria and Weighting):

 

All companies selected for inclusion in PMBI must be principally engaged in the biotechnology sector. Companies instead principally engaged in the pharmaceuticals sector will no longer be eligible for inclusion.

 

The Poliwogg Medical Breakthroughs IndexSM (TICKER: PMBI) is designed to capture research and development opportunities in the pharmaceutical industry. PMBI consists of small-cap and mid-cap biotechnology stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials.

 

Detailed information on the Poliwogg Medical Breakthroughs IndexSM including constituent data, rules and price information is available at www.poliwoggindexes.com. Data is also available through most vendors of financial data.

 

Index: Poliwogg Medical Breakthroughs IndexSM: TICKER: PMBI

 

Index: Poliwogg Medical Breakthroughs Total Return IndexSM: TICKER: PMBITR

 

 

About S-Network Global Indexes

 

S-Network Global Indexes, Inc. is a publisher and developer of proprietary and custom indexes. Founded in 1997, S-Network publishes over 200 indexes, which serve as the underlying portfolios for financial products with approximately USD 7 billion in assets under management.  S-Network indexes, which are supported by a state-of-the-art technology platform, are known for their transparency and efficiency.

 

S-Network is a prominent provider of smart beta indexes that incorporate both standard market statistics, as well as unique and highly specialized proprietary data sets derived from non-traditional sources.  Smart beta indexes developed by S-Network embrace powerful single-factor models as well as complex multi-factor models that incorporate over 200 discrete factors.  All indexes developed by S-Network address and resolve issues such as liquidity, investability and index turnover characteristics.

 

For more information please visit www.snetglobalindexes.com.

 

 

About Poliwogg

Mission

Poliwogg’s mission is to create innovative financial products that give both institutional and retail investors the widest possible opportunity to hedge and invest in the healthcare economy.

 

Company

Poliwogg is a financial services company that creates unique tools which give market participants and investors access to specific verticals in the healthcare economy.  Poliwogg products categorize investments in a number of different ways: by risk, by sector/subsector, and by particular diseases.  These groupings enable more efficient uses of capital within the healthcare sector.

 

Management Team

Poliwogg’s management team has extensive experience in finance, healthcare, and investing.  It combines that expertise with a passion for increasing and broadening investment in healthcare and for using financial tools to increase efficiency and transparency in healthcare.

Latest News

Nov 1, 2018

Rule Change for Poliwogg Medical Breakthroughs Index

Sep 14, 2018

10 Additions and 10 Deletions in Poliwogg Healthcare Innovation Index Quarterly Reconstitution

Jun 8, 2018

11 Additions and 11 Deletions in Poliwogg Healthcare Innovation Index Quarterly Reconstitution

Jun 8, 2018

31 Additions and Three Deletions in Poliwogg Biopharma Merger & Acquisition Index Semi-Annual Reconstitution

Jun 7, 2018

40 Additions and 22 Deletions in Poliwogg Medical Breakthroughs Index Semi-Annual Reconstitution

Mar 9, 2018

Five Additions and Five Deletions in Poliwogg Healthcare Innovation Index Quarterly Reconstitution

Dec 8, 2017

29 Additions and 22 Deletions in Poliwogg Medical Breakthroughs Index Semi-Annual Reconstitution

Dec 8, 2017

Five Additions and Five Deletions in Poliwogg Healthcare Innovation Index Quarterly Reconstitution

Dec 8, 2017

Nine Additions and Four Deletions in Poliwogg Biopharma Merger & Acquisition Index Semi-Annual Reconstitution

Sep 7, 2017

Five Additions and Five Deletions in Poliwogg Healthcare Innovation Index Quarterly Reconstitution

Jun 8, 2017

11 Additions and 11 Deletions in Poliwogg Healthcare Innovation Index Semi-Annual Reconstitution

Jun 8, 2017

Seven Additions and Eight Deletions in Poliwogg Biopharma Merger & Acquisition Index Semi-Annual Reconstitution

Jun 8, 2017

26 Additions and 18 Deletions in Poliwogg Medical Breakthroughs Index Semi-Annual Reconstitution

Mar 8, 2017

One Addition in Poliwogg Healthcare Innovation Index Quarterly Rebalancing

Dec 19, 2016

11 Additions and 10 Deletions in Poliwogg Healthcare Innovation Index Semi-Annual Reconstitution

Dec 9, 2016

15 Additions and 11 Deletions in Poliwogg Biopharma Merger & Acquisition Index Semi-Annual Reconstitution

Dec 8, 2016

18 Additions and 14 Deletions in Poliwogg Medical Breakthroughs Index Semi-Annual Reconstitution

Sep 15, 2016

Stephen H. Bitteker Joins S-Network as Director of Sales

Jun 14, 2016

Twelve Additions/Twelve Deletions in Poliwogg Healthcare Innovation Index Quarterly Rebalancing

Jun 8, 2016

Nine Additions/Twenty-four Deletions in Poliwogg Biopharma Merger & Acquisition Index Quarterly Rebalancing

Dec 10, 2015

Twenty-four Additions/Eleven Deletions in Poliwogg Medical Breakthroughs Index Quarterly Rebalancing

Sep 28, 2015

This Biotech ETF Has Thus Far Delivered On Its Potential

Sep 3, 2015

ETF Analysis: ALPS Medical Breakthroughs

Sep 1, 2015

6 Exceptional ETFs Up Over 15% YTD

Jul 31, 2015

A Shining Biotech Star: ALPS Medical Breakthroughs ETF

Jul 29, 2015

ETFs to Capitalize Off Obamacare Fueled Growth

Jul 24, 2015

PMBI Q2 2015 Fact Sheet

Jul 16, 2015

Is Your Biotech ETF Keeping Up With 3 New Standouts?

Jul 10, 2015

M&A Activity Will Support Pharma ETFs Through Rising Rate Environment

Jul 2, 2015

Top Performing ETF Areas of 1H

Jul 1, 2015

June ETF Performance Report

Jun 30, 2015

Top Performing ETF Areas of 1H

Jun 17, 2015

5 Healthy Stocks in the Top Biotech ETF: SBIO

Jun 11, 2015

Twenty-One Additions/Eleven Deletions in PMBI Q2 2015 Reconstitution

Jun 8, 2015

The 5 Best Money-Making Stock Market Trades of 2015: SBIO

Jun 5, 2015

SBIO Top 10 Trending ETF

May 29, 2015

Top ETF Performers of May: SBIO

May 14, 2015

A Biotech ETF to Capture the Next Breakthrough

May 9, 2015

Best ETF of the Week: SBIO

May 7, 2015

More Biotech Deal-Making Lifts a Few ETFs

Apr 23, 2015

PMBI Q1 2015 Fact Sheet

Apr 15, 2015

Best ETFs 2015 April Performance Update

Apr 2, 2015

Dyax HAE Drug Result Fuels Three Biotech ETFs

Apr 1, 2015

Healthcare ETFs Rally On Monday Merger Mania

Mar 31, 2015

Biotech ETFs in Focus After A Choppy Week

Mar 29, 2015

Selloff In Biotech, Semiconductors ETFs: A Nice Entry Point?

Mar 19, 2015

5 Biotech ETFs to Buy for Evolving Growth

Mar 5, 2015

SBIO vs BBC: 2 Innovative Biotech ETFs Head-To-Head

Feb 24, 2015

3 New, Cutting Edge ETFs Shooting Higher

Feb 12, 2015

PMBI Q4 2014 Fact Sheet

Jan 15, 2015

A New Biotech ETF Targets Companies In Late Stage Clinical Trials

Dec 31, 2014

ALPS Launches Medical Breakthroughs ETF Tracking the Poliwogg Medical Breakthroughs Index

Dec 10, 2014

Twenty-Three Additions/Nineteen Deletions in Poliwogg Medical Breakthroughs Index Quarterly Rebalancing and Rule Change

Oct 22, 2014

PMBI Q3 2013 Fact Sheet

Jun 30, 2014

PMBI Q2 2014 Fact Sheet

Jun 18, 2014

Twenty-Seven Additions/Fourteen Deletions in PMBI Q2 2014 Rebalancing

Jun 15, 2014

Fourteen Additions/Twenty-Four Deletions in Poliwogg Medical Breakthroughs Index Semi-Annual Reconstitution

Apr 9, 2014

PMBI Q1 2014 Fact Sheet